Why is Evoq Remedies falling/rising?

As of 17-Sep, Evoq Remedies Ltd's stock price is currently at 3.58, reflecting an increase of 0.11 or 3.17%. The stock has shown a trend reversal by gaining after two consecutive days of decline. Despite this recent uptick, the stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a generally bearish trend. Additionally, there has been a notable increase in investor participation, with delivery volume on 16 September rising by 100% compared to the 5-day average. However, the stock has underperformed significantly over various periods, with a year-to-date decline of 54.10% and a one-year drop of 59.64%, suggesting ongoing challenges.
In the broader market context, Evoq Remedies' recent performance contrasts sharply with the Sensex, which has gained 1.56% over the past week. The stock's short-term return of -5.04% over the last week indicates a significant underperformance compared to the benchmark. This disparity highlights the stock's struggles relative to the overall market, despite today's positive movement. The lack of available positive or negative factors further complicates the understanding of the stock's recent price movements, leaving a gap in the analysis of external influences on its performance.